Ana Radeljevic

Ana Radeljevic

Director/Board Member at MERRIMACK PHARMACEUTICALS, INC.

Net worth: 61 218 $ as of 2024-04-29

44 year
Health Technology
Consumer Services

Profile

Ana Radeljevic is currently the Chief Executive Officer at Adventus Partners since 2016.
She is also an Independent Director at Merrimack Pharmaceuticals, Inc. since 2022 and the Chief Business Officer at ADRx, Inc. since 2021.
Previously, she worked as the Vice President-Financial Planning & Analysis at Revvity, Inc. from 2014 to 2016.
Ms. Radeljevic holds an MBA from Syracuse University and an undergraduate degree from Old Dominion University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-14 4,156 ( 0.03% ) 61 218 $ 2024-04-29

Ana Radeljevic active positions

CompaniesPositionStart
MERRIMACK PHARMACEUTICALS, INC. Director/Board Member 2022-06-05
Corporate Officer/Principal 2021-08-31
All active positions of Ana Radeljevic

Former positions of Ana Radeljevic

CompaniesPositionEnd
REVVITY, INC. Corporate Officer/Principal 2015-12-31
See the detail of Ana Radeljevic's experience

Training of Ana Radeljevic

Syracuse University Masters Business Admin
Old Dominion University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ana Radeljevic's experience

Connections

21

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MERRIMACK PHARMACEUTICALS, INC.

Health Technology

REVVITY, INC.

Health Technology

Private companies1

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Ana Radeljevic